H.R. 3153 — Reported in Senate

II Calendar No. 510 116th CONGRESS 2d Session H. R. 3153 [Report No. 116–248] IN THE SENATE OF THE UNITED STATES July 24, 2019Received; read twice and referred to the Committee on Commerce, Science, and Transportation August 6, 2020Reported by Mr. Wicker, with an amendmentStrike out all after the enacting clause and insert the part printed in italic AN ACT To direct the Director of the National Science Foundation to support research on opioid addiction, and for other purposes. 1. Short title; findings (a) Short title This Act may be cited as the Expanding Findings for Federal Opioid Research and Treatment Act or the EFFORT Act. (b) Findings The Congress finds that— (1) research gaps currently exist in the prevention and treatment of opioid addiction; (2) the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and (3) the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration. 2. NSF support of research on opioid addiction The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively awarded research on the science of opioid addiction. 1. Short title; findings (a) Short title This Act may be cited as the Expanding Findings for Federal Opioid Research and Treatment Act or the EFFORT Act. (b) Findings Congress finds that— (1) research gaps exist in the prevention and treatment of opioid addiction; (2) the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and (3) the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration. 2. NSF support of research on opioid addiction (a) In general The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively-awarded research on the science of opioid addiction. (b) Authorization of appropriations To carry out this section, there are authorized to be appropriated $10,000,000 for each of fiscal years 2020 through 2024. August 6, 2020Reported with an amendment